-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Globus Medical, Lowers Price Target to $100

Benzinga·11/06/2026 13:28:00
Listen to the news
Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $117 to $100.